Author： Paraskevas Kosmas Briana Despina Liapis Christos Perrea Despina
Publisher： Springer Publishing Company
ISSN： 0301-1623
Source： International Urology and Nephrology, Vol.38, Iss.3-4, 2006-12, pp. : 683-691
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
In the last few years, renal artery stenting has gradually evolved into one of the most important therapeutic modalities in the management of atherosclerotic renovascular disease. Stenting is nowadays preferred by a steadily increasing number of physicians, not only because of its significant contribution to blood pressure control, but also because of its documented ability to maintain, and even improve, renal function. At the same time, procedure-related morbidity and mortality rates are extremely low, while recurrent stenosis rates have been repeatedly reported to be␣minimal. Percutaneous transluminal renal angioplasty (PTRA) and stenting are nowadays considered by many physicians to be the treatment of choice for atherosclerotic renovascular disease.
Related content
By Chang Jae Hyun Kim Beom Seok Oh Hyung Jung Yoo Tae-Hyun Kang Shin-Wook Lee Ho Yung Choi Donghoon Shim Won-Heum Choi Kyu Hun
Scandinavian Journal of Urology and Nephrology, Vol. 44, Iss. 3, 2010-04 ,pp. :
Access to resources
Recommend
By Mannarino Antonio Spatoliatore Giuseppe Caselli Gian Marco Toti Gabriele Becherelli Paola
Renal Failure, Vol. 34, Iss. 2, 2012-03 ,pp. :
By Geroulakos George Wright J. Gordon Tober J. Chadwick Anderson Louise Smead William L.
Annals of Vascular Surgery, Vol. 11, Iss. 1, 1997-01 ,pp. :